A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

Kidney International

Volumn 44, Issue 2, 1993, Pages 440-444

  Benigni, Ariela ^a   Zoja, Carla ^a   Corna, Daniela ^a   Orisio, Silvia ^a   Longaretti, Lorena ^a   Bertani, Tullio ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0027203495     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.263     Document Type: Article

References (27)

1. HOSTETTER TH, OLSON JL, RENNKE HG, VENKATACHALAM MA, BRENNER BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
2. ANDERSON S, MEYER TW, BRENNER BM: The role of hemodynamic factors in the initiation and progression of renal disease. J Urol 133:363-368, 1985
3. ORISIO S, BENIGNI A, BRUZZI I, CORNA D, PERICO N, ZOJA C, BENATTI L, REMUZZI G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43:354-358, 1993
4. BENIGNI A, PERICO N, GASPARI F, ZOJA C, BELLIZZI L, GABANELLI M, REMUZZI G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 260:F331-F339, 1991
5. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
6. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989
7. ARAMORI I, NIREI H, SHOUBO M, SOGABE K, NAKAMURA K, KOJO H, NOTSU Y, ONO T, NAKANISHI S: Subtype selectivity of a novel endothelin antagonist, FR 139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol Pharmacol 43:127-131, 1992
8. OLSON JL, HOSTETTER TH, RENNKE HG, BRENNER BM, VENKATACHALAM MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22:112-126, 1982
9. SOGABE K, NIREI H, SHOUBO M, HAMADA K, NOMOTO A, HENMI K, NOTSU Y, ONO T: A novel endothelial receptor antagonist: studies with FR 139317. J Vasc Res 29:201-202, 1992
10. PFEFFER JM, PFEFFER MA, FROHLICH ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962, 1971
11. READ SM, NORTHCOTE DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116:53-64, 1981
12. BONSNES RW, TAUSSKI HA: The colorimetric determination of creatinine of the Jaffé reaction. J Biol Chem 158:581, 1945
13. BERTANI T, ZOJA C, ABBATE M, ROSSINI M, REMUZZI G: Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein contents. Lab Invest 60:196-204, 1989
14. GREENBERG ME, ZIFF EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433-438, 1984
15. RAIJ L, AZAR S, KEANE W: Mesangial immune injury, hypertension, and progressive glomcrular damage in Dahl rats. Kidney Int 26:137-143, 1984
16. OKUDA S, ONOYAMA K, FUJIMI S, OH Y, NOMOTO K, OMAE T: Influence of hypertension on the progression of experimental autologous immune complex nephritis. J Lab Clin Med 101:461-471, 1983
17. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
18. KING AJ, BRENNER BM: Endothelium-derived vasoactive factors and the renal vasculature. Am J Physiol 260:R653-R662, 1991
19. PERICO N, DADAN J, GABANELLI M, REMUZZI G: Cyclooxygenase products and atrial natriuretic peptide modulate renal response to endothelin. J Pharmacol Exp Ther 252:1213-1220, 1990
20. c-src. J Biol Chem 268:9347-9357, 1993
21. SIMONSON MS, JONES JM, DUNN MJ: Differential regulation of fos and jun gene expression and AP-1 cis-element activity by endothelin isopeptides. J Biol Chem 267:8643-8649, 1992
22. TSUDA T, HAMAMORI Y, YAMASHITA T, FUKUMOTO Y, TAKAI Y: Involvement of three intracellular messenger systems, protein kinase C, calcium ion and cyclic AMP, in the regulation of c-fos gene expression in Swiss 3T3 cells. FEBS Lett 208:39-42, 1986
23. BOBIK A, GROOMS A, MILLAR JA, MITCHELL A, GRINPUKEL S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 258:C408-C415, 1990
24. ISHIMURA E, SHOUJI S, NISHIZAWA Y, MORII H, KASHGARIAN M: Regulation of mRNA expression for extracellular matrix (ECM) by cultured rat mesangial cells (MCs). (abstract) J Am Soc Nephrol 2:546, 1991
25. BRUUN JA, HOGENDOORN PCW, HOEDEMAEKER PJ, FLEUREN GJ: The extracellular matrix in pathology. J Lab Clin Med 111:140-149, 1988
26. HORI S, KOMATSU Y, SHIGEMOTO R, MZUNO N, NAKANISHI S: Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130:1885-1895, 1992
27. MARTIN ER, BRENNER BM, BALLERMAN BJ: Heterogeneity of cell surface endothelin receptors. J Biol Chem 265:14044-14049, 1990